Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit.
about
Renin gene polymorphisms in bangladeshi hypertensive populationPersonalized vascular medicine: individualizing drug therapyGenetic influences of angiotensin-converting enzyme inhibitor response: an opportunity for personalizing therapy?Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.Interactions of renin-angiotensin system gene polymorphisms and antihypertensive effect of benazepril in Chinese population.Effect of NR3C2 genetic polymorphisms on the blood pressure response to enalapril treatment.
P2860
Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tailored therapy of ACE inhibi ...... rofiling of treatment benefit.
@en
Tailored therapy of ACE inhibi ...... rofiling of treatment benefit.
@nl
type
label
Tailored therapy of ACE inhibi ...... rofiling of treatment benefit.
@en
Tailored therapy of ACE inhibi ...... rofiling of treatment benefit.
@nl
prefLabel
Tailored therapy of ACE inhibi ...... rofiling of treatment benefit.
@en
Tailored therapy of ACE inhibi ...... rofiling of treatment benefit.
@nl
P2860
P356
P1433
P1476
Tailored therapy of ACE inhibi ...... rofiling of treatment benefit.
@en
P2093
Jasper J Brugts
P2860
P304
P356
10.2217/PGS.10.103
P577
2010-08-01T00:00:00Z